Cellcyte Genetics Corp (CCYG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Assets | |||||
| Current Assets | |||||
| TOTAL | $2 | $1 | $1 | $9 | $17 |
| Non-Current Assets | |||||
| Intangibles | 0 | 0 | 0 | 0 | 11 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $11 |
| Total Assets | $2 | $1 | $1 | $9 | $28 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 149 | 144 | 127 | 126 | 111 |
| Accrued Expenses | 113 | 103 | 93 | 82 | 153 |
| Other current liabilities | 118 | 118 | 118 | 141 | 141 |
| TOTAL | $380 | $365 | $338 | $351 | $416 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 538 | 524 | 516 | 478 | 386 |
| TOTAL | $538 | $524 | $516 | $478 | $386 |
| Total Liabilities | $917 | $889 | $854 | $829 | $802 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 82,329 | 82,329 | 82,329 | 82,329 | 82,329 |
| Common Shares | 82 | 82 | 82 | 82 | 82 |
| Retained earnings | -12,781 | -12,754 | -12,718 | -12,685 | -12,639 |
| Other shareholders' equity | 5 | 49 | 49 | 49 | 49 |
| TOTAL | $-916 | $-888 | $-853 | $-820 | $-774 |
| Total Liabilities And Equity | $2 | $1 | $1 | $9 | $28 |